PanGenomic Health Inc

NEW
HAM:LL3 (Canada)  
€ 0.12 (0%) Apr 1
At Loss
Market Cap:
€ 987.00K ($ 1.07M)
Enterprise V:
€ 1.59M ($ 1.71M)
Volume:
-
Avg Vol (2M):
4.75K
Trade In:
What is a stock summary page? Click here for an overview.

Business Description

Description
PanGenomic Health Inc is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments to support mental health. The company's mobile app, the Nara App, provides consumers with a knowledge base tailored to an individual's user profile, developed by tracking a user's treatment regimen and their specific genomic, proteomics, and microbiome data. The Company's mission is to promote and improve the health and wellness of people and society by providing a technology platform that identifies plant-based solutions tailored to the health profile of each individual.
Name Current Vs Industry Vs History
Cash-To-Debt 0.03
Equity-to-Asset -26.11
Debt-to-Equity -0.59
Debt-to-EBITDA -0.28
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 33.69
9-Day RSI 45.35
14-Day RSI 48.5
3-1 Month Momentum % 17.66
6-1 Month Momentum % -42.55
12-1 Month Momentum % -71.08

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.04
Quick Ratio 0.04
Cash Ratio 0.02

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % -48.29
Name Current Vs Industry Vs History
ROA % -3928.41
ROIC % -222.05
ROC (Joel Greenblatt) % -45500

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -0.71
EV-to-EBITDA -0.71
EV-to-FCF -5.99
Earnings Yield (Greenblatt) % -141.1
FCF Yield % -24.25

Financials

HAM:LL3's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

PanGenomic Health Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €)
EPS (TTM) (€) -1.161
Beta -
3-Year Sharpe Ratio -
3-Year Sortino Ratio -
Volatility % -
14-Day RSI 48.5
14-Day ATR (€) 0.008923
20-Day SMA (€) 0.12745
12-1 Month Momentum % -71.08
52-Week Range (€) 0.0546 - 0.36
Shares Outstanding (Mil) 6.4

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

PanGenomic Health Inc Filings

Filing Date Document Date Form
No Filing Data

PanGenomic Health Inc Stock Events

Financials Calendars
Event Date Price (€)
No Event Data

PanGenomic Health Inc Frequently Asked Questions

What is PanGenomic Health Inc(HAM:LL3)'s stock price today?
The current price of HAM:LL3 is €0.12. The 52 week high of HAM:LL3 is €0.36 and 52 week low is €0.05.
When is next earnings date of PanGenomic Health Inc(HAM:LL3)?
The next earnings date of PanGenomic Health Inc(HAM:LL3) is .
Does PanGenomic Health Inc(HAM:LL3) pay dividends? If so, how much?
PanGenomic Health Inc(HAM:LL3) does not pay dividend.

Press Release

Subject Date
No Press Release